Skip to main content

Table 2 Preoperative and operative findings of PET/CT in patients who underwent operation (n = 133)

From: The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma

  

n

FDG uptake in primary tumor

FDG uptake in local LN

   

Yes (%)

(n = 117)

No (%)

(n = 16)

p-value

Yes (%)

(n = 29)

No (%)

(n = 104)

p-value

Age(years)

< 60

53

46(86.8)

7(12.1)

0.734

11(20.8)

42(79.2)

0.811

 

≥ 60

80

71(88.8)

9(10.7)

 

18(22.5)

62(77.5)

 

Gender

Male

92

82(89.1)

10(10.9)

0.570

22(23.9)

70(76.1)

0.378

 

Female

41

35(85.4)

6(14.6)

 

7(17.1)

34(82.9)

 

DM

Positive

18

16(88.9)

2(11.1)

1.000

5(27.8)

13(72.2)

0.543

 

Negative

115

101(87.8)

14(12.2)

 

24(20.9)

91(79.1)

 

Size(cm)

< 5

65

54(83.1)

11(16.9)

0.090

10(15.4)

55(84.6)

0.080

 

≥ 5

68

63(92.6)

5(7.4)

 

19(27.9)

49(72.1)

 

Location

Upper

22

20(90.9)

2(9.1)

1.000

5(22.7)

17(77.3)

0.909

 

Middle and lower

111

97(87.4)

14(12.6)

 

24(21.6)

87(78.4)

 

Histology

Tubular carcinoma

108

95(88.0)

13(12.0)

1.000

25(23.1)

83(76.9)

0.435

 

Signet ring/mucinous

25

22(88.0)

3(12.0)

 

4(16.0)

21(84.0)

 

Curability

Curative operation

99

84(84.8)

15(15.2)

0.047

14(14.1)

85(85.9)

< 0.001

 

Non-curative operation

34

33(97.1)

1(2.9)

 

15(44.1)

19(55.9)

 
  1. PET, positron emission tomography, CT, computed tomography, FDG, fluorodeoxyglucose, LN, lymph nodes, DM, diabetes mellitus